| NCT06588491 | KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome | RECRUITING | PHASE2 | 2024-09-25 | 2026-12 | 2026-04 |
| NCT06384976 | KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-09-20 | 2029-01 | 2027-04 |
| NCT06193889 | KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis | RECRUITING | PHASE2, PHASE3 | 2024-08-28 | 2028-09 | 2027-09 |
| NCT06400303 | KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2024-08-06 | 2027-03 | 2026-03 |
| NCT05938725 | KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis | RECRUITING | PHASE1, PHASE2 | 2023-04-28 | 2026-08 | 2025-08 |
| NCT06342960 | KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis | RECRUITING | PHASE1, PHASE2 | 2022-12-01 | 2029-01 | 2028-10 |